Entrada Therapeutics (TRDA) EPS (Basic) (2020 - 2026)
Entrada Therapeutics (TRDA) posted quarterly EPS (Basic) of -$0.95 for Q1 2026, down 124.76% year-over-year from $3.83 in Q1 2025, and little changed quarter-over-quarter from -$0.95 in Q4 2025.
Powered by 
Analysis
Entrada Therapeutics (TRDA) EPS (Basic) (2020 - 2026) Analysis & Trends
Entrada Therapeutics' EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.95 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 124.76% year-over-year to -$0.95; the TTM figure through Mar 2026 stood at -$3.97 (down 759.36% YoY), while the FY2025 annual figure was -$3.47, down 297.49% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.95, roughly flat from -$0.95 in the prior quarter.
- The five-year high for EPS (Basic) was $1.61 in Q2 2024, with the low at -$1.06 in Q3 2025.
- The 5-year median for EPS (Basic) is -$0.69 (2022), against an average of -$0.33.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 440.25% in 2024, then sank 3223.17% in 2025.
- Entrada Therapeutics' EPS (Basic) stood at -$0.79 in 2022, then soared by 63.47% to -$0.29 in 2023, then jumped by 110.54% to $0.03 in 2024, then tumbled by 3223.17% to -$0.95 in 2025, then fell by 0.26% to -$0.95 in 2026.
- Business Quant data shows TRDA's EPS (Basic) at -$0.95 in Q1 2026, -$0.95 in Q4 2025, and -$1.06 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Entrada Therapeutics | 301.04 Mn | 301.04 Mn | - | -1.01 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 |
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -0.95 |
| Sep 30, 2025 | -1.07 |
| Jun 30, 2025 | -1.04 |
| Mar 31, 2025 | -0.42 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | -0.34 |
| Jun 30, 2024 | 1.61 |
| Mar 31, 2024 | 0.70 |
| Dec 31, 2023 | -0.29 |
| Sep 30, 2023 | 1.07 |
| Jun 30, 2023 | -0.78 |
| Mar 31, 2023 | -0.21 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -0.80 |
| Jun 30, 2022 | -0.74 |
| Mar 31, 2022 | -0.69 |
| Dec 31, 2021 | -2.94 |
| Sep 30, 2021 | -9.78 |